Today’s Market Movers: Emcure to Godfrey Phillips Shine Amid Sector Rotation
Pharma Strength, Bank Updates and Infrastructure Bets Dominate Trading Focus
A detailed look at nine key names including Emcure, Aurobindo Pharma and Tata Steel that could outperform following recent corporate and macro developments. Investors may reposition as pharma, metals and utilities show fresh momentum.
Market Overview
The Indian benchmark indices closed mixed on Friday with volatility persisting amid global rate outlook uncertainty. The Nifty 50 ended marginally lower, while the broader markets saw rotation into defensive segments. Foreign fund flows remain cautious ahead of US inflation data and domestic monsoon forecasts. Against this backdrop, attention is on sectors with stable earnings visibility and cyclical recovery potential.
Stock-Specific Analysis
Emcure Pharmaceuticals has garnered interest after reporting resilient margin performance and upward revision in export volumes. Analysts highlight its step-up in specialty formulations as a key earnings driver over the next two quarters. Aurobindo Pharma remains in focus after fresh approvals from the US Food and Drug Administration, supporting healthy revenue growth and cash flow visibility.
HFCL saw buying interest riding on telecom capex expectations. The company’s robust order book and strategic tie-ups for fibre-to-home solutions could underpin double-digit earnings growth in fiscal year 2025. RBL Bank is on watch following management’s cautious commentary on asset quality and fresh restructuring norms; any clarity on credit costs could trigger fresh re-rating.
Coal India may benefit from firm global coal prices and improved domestic dispatches. Infrastructure spending plans signal steady demand for thermal coal, while state utilities strive to build buffer stocks ahead of the rainy season. Tata Steel’s earnings outlook looks upbeat as spreads in Europe and India improve, with capacity utilisation inching higher at its plant in Jamshedpur.
Hospitality leader ITC Hotels is enjoying a revival in domestic travel and corporate events. Recovery in average room rates and occupancy above pre-pandemic levels could lend support. Power Grid Corporation stands out among utilities for its consistent dividend track record and sizable capex plan to strengthen interstate transmission corridors.
Godfrey Phillips India has attracted attention on hopes of pricing gains and stable volume in cigarettes. Management commentary suggests margins could expand with lower leaf tobacco costs, offsetting share gains in key regions. Investors are watching quarterly numbers closely for volume trends and tax-led price hikes.
Sectoral Performance
Pharmaceuticals have outperformed amid safe-haven buying and export tailwinds. Metals names like Tata Steel are benefiting from a rebound in commodity spreads and lower Indonesian ore imports. Banks are under consolidation pressure but select mid-cap lenders offer attractive valuations post recent sell-off. Utilities and infrastructure stocks remain defensive plays given steady cash flows and government capex commitments.
Key Highlights
- Emcure Pharmaceuticals Q4 EBITDA margin expanded to 17.5%, driven by improved mix.
- Aurobindo Pharma secured 3 new ANDA approvals in the US, taking its total to 240.
- HFCL order book stands at ₹3,100 crore supporting medium-term revenue guidance.
- Coal India plans to dispatch 660 million tonnes in FY24, up 3.5% year on year.
- Tata Steel’s European spread has rebounded by 10% since late April.
Investor Note: Investors seeking a balanced portfolio view may consider rebalancing into these names based on risk appetite and time horizon. Pharma offers defensive growth, metals can capture cyclical recovery, and utilities provide stable income. Monitor global rate cues and domestic monsoon developments for macro tailwinds.